143 related articles for article (PubMed ID: 36353214)
1. Bioinformatics Approaches to Predict Mutation Effects in the Binding Site of the Proangiogenic Molecule CD93.
Cicaloni V; Karmakar M; Frusciante L; Pettini F; Visibelli A; Orlandini M; Galvagni F; Mongiat M; Silk M; Nardi F; Ascher D; Santucci A; Spiga O
Front Bioinform; 2022; 2():891553. PubMed ID: 36353214
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium.
Galvagni F; Nardi F; Spiga O; Trezza A; Tarticchio G; Pellicani R; Andreuzzi E; Caldi E; Toti P; Tosi GM; Santucci A; Iozzo RV; Mongiat M; Orlandini M
Matrix Biol; 2017 Dec; 64():112-127. PubMed ID: 28912033
[TBL] [Abstract][Full Text] [Related]
3. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.
Khan KA; Naylor AJ; Khan A; Noy PJ; Mambretti M; Lodhia P; Athwal J; Korzystka A; Buckley CD; Willcox BE; Mohammed F; Bicknell R
Oncogene; 2017 Nov; 36(44):6097-6108. PubMed ID: 28671670
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis modulated by CD93 and its natural ligands IGFBP7 and MMRN2: a new target to facilitate solid tumor therapy by vasculature normalization.
Li Y; Fu L; Wu B; Guo X; Shi Y; Lv C; Yu Y; Zhang Y; Liang Z; Zhong C; Han S; Xu F; Tian Y
Cancer Cell Int; 2023 Sep; 23(1):189. PubMed ID: 37660019
[TBL] [Abstract][Full Text] [Related]
5. Dimerization of the C-type lectin-like receptor CD93 promotes its binding to Multimerin-2 in endothelial cells.
Barbera S; Raucci L; Tassone G; Tinti L; Prischi F; Santucci A; Mongiat M; Tosi GM; Galvagni F; Dimberg A; Pozzi C; Orlandini M
Int J Biol Macromol; 2023 Jan; 224():453-464. PubMed ID: 36265539
[TBL] [Abstract][Full Text] [Related]
6. CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.
Lugano R; Vemuri K; Yu D; Bergqvist M; Smits A; Essand M; Johansson S; Dejana E; Dimberg A
J Clin Invest; 2018 Aug; 128(8):3280-3297. PubMed ID: 29763414
[TBL] [Abstract][Full Text] [Related]
7. CD93 negatively regulates astrogenesis in response to MMRN2 through the transcriptional repressor ZFP503 in the developing brain.
Liang Q; Su L; Zhang D; Jiao J
Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9413-9422. PubMed ID: 32291340
[TBL] [Abstract][Full Text] [Related]
8. Soluble expression of disulfide-bonded C-type lectin like domain of human CD93 in the cytoplasm of Escherichia coli.
Nativel B; Figuester A; Andries J; Planesse C; Couprie J; Gasque P; Viranaicken W; Iwema T
J Immunol Methods; 2016 Dec; 439():67-73. PubMed ID: 27742562
[TBL] [Abstract][Full Text] [Related]
9. The small GTPase Rab5c is a key regulator of trafficking of the CD93/Multimerin-2/β1 integrin complex in endothelial cell adhesion and migration.
Barbera S; Nardi F; Elia I; Realini G; Lugano R; Santucci A; Tosi GM; Dimberg A; Galvagni F; Orlandini M
Cell Commun Signal; 2019 May; 17(1):55. PubMed ID: 31138217
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound Imaging of Tumor Vascular CD93 with MMRN2 Modified Microbubbles for Immune Microenvironment Prediction.
Wang D; Xing C; Liang Y; Wang C; Zhao P; Liang X; Li Q; Yuan L
Adv Mater; 2024 May; 36(18):e2310421. PubMed ID: 38270289
[TBL] [Abstract][Full Text] [Related]
11. CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration adhesion and migration.
Galvagni F; Nardi F; Maida M; Bernardini G; Vannuccini S; Petraglia F; Santucci A; Orlandini M
Oncotarget; 2016 Mar; 7(9):10090-103. PubMed ID: 26848865
[TBL] [Abstract][Full Text] [Related]
12. CD93 is a cell surface lectin receptor involved in the control of the inflammatory response stimulated by exogenous DNA.
Nativel B; Ramin-Mangata S; Mevizou R; Figuester A; Andries J; Iwema T; Ikewaki N; Gasque P; Viranaïcken W
Immunology; 2019 Oct; 158(2):85-93. PubMed ID: 31335975
[TBL] [Abstract][Full Text] [Related]
13. Structural insight into CD93 recognition by IGFBP7.
Xu Y; Sun Y; Zhu Y; Song G
bioRxiv; 2023 Jun; ():. PubMed ID: 37333140
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy.
Sun Y; Chen W; Torphy RJ; Yao S; Zhu G; Lin R; Lugano R; Miller EN; Fujiwara Y; Bian L; Zheng L; Anand S; Gao F; Zhang W; Ferrara SE; Goodspeed AE; Dimberg A; Wang XJ; Edil BH; Barnett CC; Schulick RD; Chen L; Zhu Y
Sci Transl Med; 2021 Jul; 13(604):. PubMed ID: 34321321
[TBL] [Abstract][Full Text] [Related]
15. Structural insight into CD93 recognition by IGFBP7.
Xu Y; Sun Y; Zhu Y; Song G
Structure; 2024 Mar; 32(3):282-291.e4. PubMed ID: 38218180
[TBL] [Abstract][Full Text] [Related]
16. The C-type lectin CD93 controls endothelial cell migration via activation of the Rho family of small GTPases.
Barbera S; Lugano R; Pedalina A; Mongiat M; Santucci A; Tosi GM; Dimberg A; Galvagni F; Orlandini M
Matrix Biol; 2021 May; 99():1-17. PubMed ID: 34062268
[TBL] [Abstract][Full Text] [Related]
17. The angiostatic molecule Multimerin 2 is processed by MMP-9 to allow sprouting angiogenesis.
Andreuzzi E; Colladel R; Pellicani R; Tarticchio G; Cannizzaro R; Spessotto P; Bussolati B; Brossa A; De Paoli P; Canzonieri V; Iozzo RV; Colombatti A; Mongiat M
Matrix Biol; 2017 Dec; 64():40-53. PubMed ID: 28435016
[TBL] [Abstract][Full Text] [Related]
18. Multimerin-2 orchestrates the cross-talk between endothelial cells and pericytes: A mechanism to maintain vascular stability.
Fejza A; Poletto E; Carobolante G; Camicia L; Andreuzzi E; Capuano A; Pivetta E; Pellicani R; Colladel R; Marastoni S; Doliana R; Iozzo RV; Spessotto P; Mongiat M
Matrix Biol Plus; 2021 Aug; 11():100068. PubMed ID: 34435184
[TBL] [Abstract][Full Text] [Related]
19. Multimerin-2 maintains vascular stability and permeability.
Pellicani R; Poletto E; Andreuzzi E; Paulitti A; Doliana R; Bizzotto D; Braghetta P; Colladel R; Tarticchio G; Sabatelli P; Bucciotti F; Bressan G; Iozzo RV; Colombatti A; Bonaldo P; Mongiat M
Matrix Biol; 2020 May; 87():11-25. PubMed ID: 31422156
[TBL] [Abstract][Full Text] [Related]
20. Modulated interaction of the ERM protein, moesin, with CD93.
Zhang M; Bohlson SS; Dy M; Tenner AJ
Immunology; 2005 May; 115(1):63-73. PubMed ID: 15819698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]